Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide dismutase 1 (SOD1), also known as Cu/Zn superoxide dismutase, is a highly abundant, homodimeric antioxidant enzyme primarily localized in the cytosol, nucleus, and mitochondrial intermembrane space. Its primary physiological function is to catalyze the dismutation of toxic superoxide radicals into molecular oxygen and hydrogen peroxide, thereby protecting cells from oxidative stress and regulating redox-sensitive signaling pathways. Mutations in the SOD1 gene are a well-established cause of familial amyotrophic lateral sclerosis (ALS), where mutant SOD1 proteins undergo pathological misfolding and aggregation, exerting a toxic gain-of-function that leads to motor neuron degeneration. In oncology, SOD1 is often overexpressed in various cancers, such as non-small cell lung cancer, where it helps tumor cells cope with elevated reactive oxygen species (ROS) levels. Therapeutically, SOD1 is targeted using different modalities depending on the disease context. In ALS, the FDA-approved antisense oligonucleotide tofersen (Qalsody) binds to SOD1 mRNA, promoting its degradation and reducing the synthesis of both wild-type and toxic mutant SOD1 proteins. In cancer, small molecule inhibitors like LCS-1 and copper-chelating agents like choline tetrathiomolybdate (ATN-224) are investigated to inhibit SOD1 enzymatic activity, leading to toxic ROS accumulation, p38 MAPK activation, and subsequent apoptosis of cancer cells.
Antisense oligonucleotide-mediated mRNA degradation to reduce protein synthesis; small molecule enzymatic inhibition to increase intracellular reactive oxygen species and induce apoptosis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide dismutase 1 (SOD1).